Ginger (Zingiber officinale) in the Management of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: Integrative Literature Review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | por eng spa |
Título da fonte: | Revista Brasileira de Cancerologia (Online) |
Texto Completo: | https://rbc.inca.gov.br/index.php/revista/article/view/3592 |
Resumo: | Introduction: Chemotherapy-induced nausea and vomiting (CINV) are important side effects of antineoplastic treatments. Some medicinal plants have been studied in the management of these effects, such as ginger (Zingiber officinale). Objective: Review the oral use of ginger in the management of CINV in cancer patients. Method: Integrative literature review carried out at the MEDLINE database, in September 2022, utilizing the combination of the keywords “Zingiber officinale” and “Cancer”, filters were also applied to include randomized clinical trials published between 2012 and 2022. Results: In all, nine studies were analyzed. Ginger has the potential to reduce CINV in cancer patients, reflecting positively on quality-of-life, improved appetite and fatigue. The studies have not found any adverse effect after administering ginger. Conclusion: The oral use of ginger proves to be an effective strategy for the management of CINV in cancer patients, in the dosage regimen of 1 g/day of powdered ginger, and can be used as a complementary therapy along with standard antiemetic regimens. |
id |
INCA-1_7f053eee84857f5f6d7fb05810a67e76 |
---|---|
oai_identifier_str |
oai:rbc.inca.gov.br:article/3592 |
network_acronym_str |
INCA-1 |
network_name_str |
Revista Brasileira de Cancerologia (Online) |
repository_id_str |
|
spelling |
Ginger (Zingiber officinale) in the Management of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: Integrative Literature ReviewJengibre (Zingiber officinale) en el Tratamiento de las Náuseas y los Vómitos Inducidos por la Quimioterapia en Pacientes con Cáncer: Revisión Integradora de la LiteraturaGengibre (Zingiber officinale) no Manejo de Náuseas e Vômitos Induzidos por Quimioterapia em Pacientes com Câncer: Revisão Integrativa da Literaturaneoplasias/tratamento farmacológicogengibre/efeitos adversosplantas medicinaisfitoterapianeoplasms/drug therapyginger/adverse effectsplants, medicinalphytotherapyneoplasias/tratamiento farmacológicojengibre/efectos adversosplantas medicinalesfitoterapiaIntroduction: Chemotherapy-induced nausea and vomiting (CINV) are important side effects of antineoplastic treatments. Some medicinal plants have been studied in the management of these effects, such as ginger (Zingiber officinale). Objective: Review the oral use of ginger in the management of CINV in cancer patients. Method: Integrative literature review carried out at the MEDLINE database, in September 2022, utilizing the combination of the keywords “Zingiber officinale” and “Cancer”, filters were also applied to include randomized clinical trials published between 2012 and 2022. Results: In all, nine studies were analyzed. Ginger has the potential to reduce CINV in cancer patients, reflecting positively on quality-of-life, improved appetite and fatigue. The studies have not found any adverse effect after administering ginger. Conclusion: The oral use of ginger proves to be an effective strategy for the management of CINV in cancer patients, in the dosage regimen of 1 g/day of powdered ginger, and can be used as a complementary therapy along with standard antiemetic regimens.Introducción: Las náuseas y los vómitos inducidos por la quimioterapia (NVIQ) son efectos secundarios importantes de los tratamientos antineoplásicos. Se han estudiado algunas plantas medicinales en el manejo de estos efectos, como el jengibre (Zingiber officinale). Objetivo: Realizar una revisión integradora de la literatura sobre el uso oral del jengibre en el manejo de las NVIQ en pacientes oncológicos. Método: Revisión integradora de la literatura realizada en la base de datos MEDLINE, en septiembre de 2022, adoptando la combinación de las palabras clave “Zingiber officinale” y “Cancer”. También se aplicaron filtros en la selección para incluir ensayos clínicos aleatorizados publicados entre 2012 y 2022. Resultados: En total, se analizaron nueve estudios. El jengibre tiene el potencial de reducir las NVIQ en pacientes con cáncer, lo que se refleja positivamente en la mejora de la calidad de vida, apetito y fatiga. Los estudios no han observado ningún efecto adverso por la administración del jengibre. Conclusión: El uso del jengibre por vía oral demuestra ser una estrategia segura para el manejo de NVIQ en pacientes con cáncer, usando una dosis de 1 g/día de jengibre en polvo, y puede usarse como terapia complementaria junto con los regímenes antieméticos estándar.Introdução: Náuseas e vômitos induzidos por quimioterapia (NVIQ) são importantes efeitos colaterais dos tratamentos antineoplásicos. Algumas plantas medicinais vêm sendo estudadas no manejo desses efeitos, como o gengibre (Zingiber officinale). Objetivo: Realizar uma revisão acerca do uso via oral do gengibre no manejo de NVIQ em pacientes com câncer. Método: Revisão integrativa da literatura realizada na base de dados MEDLINE, em setembro de 2022, adotando a combinação das palavras-chave “Zingiber officinale” e “Cancer”. Foram também aplicados filtros na seleção para incluir ensaios clínicos aleatórios publicados entre 2012 e 2022. Resultados: Ao todo, foram analisados nove estudos. O gengibre apresenta potencial de reduzir NVIQ em pacientes com câncer, refletindo positivamente na qualidade de vida e na melhora do apetite e da fadiga. Os estudos não observaram efeitos adversos da administração do gengibre. Conclusão: O uso por via oral do gengibre demonstra ser uma estratégia segura para o manejo de NVIQ em pacientes com câncer, na dose de 1 g/dia do gengibre em pó, podendo ser utilizado como terapia complementar juntamente com regimes antieméticos padrões.INCA2023-03-21info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionRevisão de literaturaapplication/pdfapplication/pdfapplication/pdftext/htmlhttps://rbc.inca.gov.br/index.php/revista/article/view/359210.32635/2176-9745.RBC.2023v69n2.3592Revista Brasileira de Cancerologia; Vol. 69 No. 2 (2023): Apr./May/June; e-033592Revista Brasileira de Cancerologia; Vol. 69 Núm. 2 (2023): abr./mayo/jun.; e-033592Revista Brasileira de Cancerologia; v. 69 n. 2 (2023): abr./maio/jun.; e-0335922176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAporengspahttps://rbc.inca.gov.br/index.php/revista/article/view/3592/2735https://rbc.inca.gov.br/index.php/revista/article/view/3592/3261https://rbc.inca.gov.br/index.php/revista/article/view/3592/3015https://rbc.inca.gov.br/index.php/revista/article/view/3592/2746Copyright (c) 2023 Revista Brasileira de Cancerologiahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessFerreira, Wagner AndradeNeves, Vivian dos SantosFiut, Maria AngélicaFranco, Emília DelesderrierRodrigues, Cláudia dos Santos Cople2023-12-01T18:55:25Zoai:rbc.inca.gov.br:article/3592Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2023-12-01T18:55:25Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false |
dc.title.none.fl_str_mv |
Ginger (Zingiber officinale) in the Management of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: Integrative Literature Review Jengibre (Zingiber officinale) en el Tratamiento de las Náuseas y los Vómitos Inducidos por la Quimioterapia en Pacientes con Cáncer: Revisión Integradora de la Literatura Gengibre (Zingiber officinale) no Manejo de Náuseas e Vômitos Induzidos por Quimioterapia em Pacientes com Câncer: Revisão Integrativa da Literatura |
title |
Ginger (Zingiber officinale) in the Management of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: Integrative Literature Review |
spellingShingle |
Ginger (Zingiber officinale) in the Management of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: Integrative Literature Review Ferreira, Wagner Andrade neoplasias/tratamento farmacológico gengibre/efeitos adversos plantas medicinais fitoterapia neoplasms/drug therapy ginger/adverse effects plants, medicinal phytotherapy neoplasias/tratamiento farmacológico jengibre/efectos adversos plantas medicinales fitoterapia |
title_short |
Ginger (Zingiber officinale) in the Management of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: Integrative Literature Review |
title_full |
Ginger (Zingiber officinale) in the Management of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: Integrative Literature Review |
title_fullStr |
Ginger (Zingiber officinale) in the Management of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: Integrative Literature Review |
title_full_unstemmed |
Ginger (Zingiber officinale) in the Management of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: Integrative Literature Review |
title_sort |
Ginger (Zingiber officinale) in the Management of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: Integrative Literature Review |
author |
Ferreira, Wagner Andrade |
author_facet |
Ferreira, Wagner Andrade Neves, Vivian dos Santos Fiut, Maria Angélica Franco, Emília Delesderrier Rodrigues, Cláudia dos Santos Cople |
author_role |
author |
author2 |
Neves, Vivian dos Santos Fiut, Maria Angélica Franco, Emília Delesderrier Rodrigues, Cláudia dos Santos Cople |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Ferreira, Wagner Andrade Neves, Vivian dos Santos Fiut, Maria Angélica Franco, Emília Delesderrier Rodrigues, Cláudia dos Santos Cople |
dc.subject.por.fl_str_mv |
neoplasias/tratamento farmacológico gengibre/efeitos adversos plantas medicinais fitoterapia neoplasms/drug therapy ginger/adverse effects plants, medicinal phytotherapy neoplasias/tratamiento farmacológico jengibre/efectos adversos plantas medicinales fitoterapia |
topic |
neoplasias/tratamento farmacológico gengibre/efeitos adversos plantas medicinais fitoterapia neoplasms/drug therapy ginger/adverse effects plants, medicinal phytotherapy neoplasias/tratamiento farmacológico jengibre/efectos adversos plantas medicinales fitoterapia |
description |
Introduction: Chemotherapy-induced nausea and vomiting (CINV) are important side effects of antineoplastic treatments. Some medicinal plants have been studied in the management of these effects, such as ginger (Zingiber officinale). Objective: Review the oral use of ginger in the management of CINV in cancer patients. Method: Integrative literature review carried out at the MEDLINE database, in September 2022, utilizing the combination of the keywords “Zingiber officinale” and “Cancer”, filters were also applied to include randomized clinical trials published between 2012 and 2022. Results: In all, nine studies were analyzed. Ginger has the potential to reduce CINV in cancer patients, reflecting positively on quality-of-life, improved appetite and fatigue. The studies have not found any adverse effect after administering ginger. Conclusion: The oral use of ginger proves to be an effective strategy for the management of CINV in cancer patients, in the dosage regimen of 1 g/day of powdered ginger, and can be used as a complementary therapy along with standard antiemetic regimens. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-03-21 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Revisão de literatura |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rbc.inca.gov.br/index.php/revista/article/view/3592 10.32635/2176-9745.RBC.2023v69n2.3592 |
url |
https://rbc.inca.gov.br/index.php/revista/article/view/3592 |
identifier_str_mv |
10.32635/2176-9745.RBC.2023v69n2.3592 |
dc.language.iso.fl_str_mv |
por eng spa |
language |
por eng spa |
dc.relation.none.fl_str_mv |
https://rbc.inca.gov.br/index.php/revista/article/view/3592/2735 https://rbc.inca.gov.br/index.php/revista/article/view/3592/3261 https://rbc.inca.gov.br/index.php/revista/article/view/3592/3015 https://rbc.inca.gov.br/index.php/revista/article/view/3592/2746 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2023 Revista Brasileira de Cancerologia https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2023 Revista Brasileira de Cancerologia https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf text/html |
dc.publisher.none.fl_str_mv |
INCA |
publisher.none.fl_str_mv |
INCA |
dc.source.none.fl_str_mv |
Revista Brasileira de Cancerologia; Vol. 69 No. 2 (2023): Apr./May/June; e-033592 Revista Brasileira de Cancerologia; Vol. 69 Núm. 2 (2023): abr./mayo/jun.; e-033592 Revista Brasileira de Cancerologia; v. 69 n. 2 (2023): abr./maio/jun.; e-033592 2176-9745 reponame:Revista Brasileira de Cancerologia (Online) instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) instacron:INCA |
instname_str |
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) |
instacron_str |
INCA |
institution |
INCA |
reponame_str |
Revista Brasileira de Cancerologia (Online) |
collection |
Revista Brasileira de Cancerologia (Online) |
repository.name.fl_str_mv |
Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) |
repository.mail.fl_str_mv |
rbc@inca.gov.br |
_version_ |
1797042236428386304 |